South Korea Self Monitoring Blood Glucose Devices Market Insight
Published: 23 June 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The South Korea Self Monitoring Blood Glucose Devices Market is expected to grow at a CAGR of 6.12% due to increasing demand for diabetes management, rapid geriatric population growth, expanding healthcare infrastructure, and rising deployment of advanced digital tracking platforms.
South Korea Self Monitoring Blood Glucose Devices Market Insights Forecasts to 2035
- The South Korea Self Monitoring Blood Glucose Devices Market Size Was Estimated USD 185.2 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.12% from 2025 to 2035
- The South Korea Self Monitoring Blood Glucose Devices Market Size is Expected to rise around USD 335.4 Million by 2035
Notable Insights for the South Korea Self Monitoring Blood Glucose Devices Market
- The Blood Glucose Meters & Integrated Digital Strips segment secured a dominant 54% market share in 2025, driven by high adoption in South Korea's major clinical centers and domestic patient monitoring setups.
- Fueled by rising demand for regular, decentralized diagnostic tracking and high-yield operational efficiency, Type 2 Diabetes Management led the market in 2025 with a dominant 57% market share.
- Driven by strong global demand for connected biosensors and automated metabolic tracking platforms, leading multi-national device innovators projected fiscal year 2025 worldwide medical diagnostic revenue at approximately $1.8 billion.
- Market growth accelerates as clinical networks modernize, utilizing automated tracking systems and resource-efficient diagnostic tools to achieve 34% cost savings and reduce patient diagnostic error rates by 27%.
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in patient-led chronic care, modernization in diagnostic framework delivery, and development in automated biosensing technology on the South Korea Self Monitoring Blood Glucose Devices Market growth.
- Provides strategic insights regarding technology innovation such as automated data synchronization, artificial intelligence-based glycemic trend analysis technology, smart sensor instruments, and real-time biometric tracking technology.
- Assists players to analyze competitive benchmarking, investment in medical diagnostic technology, automation in personal health platforms, and expansion in specialized healthcare equipment by major tracking framework suppliers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Self Monitoring Blood Glucose Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Self Monitoring Blood Glucose Devices Market
- i-SENS, Inc.
- SD Biosensor, Inc.
- Roche Diabetes Care Korea
- Abbott Laboratories South Korea
- Ascensia Diabetes Care Korea
- Lifescan Korea
- Alltech Co., Ltd.
- Ceragem Medisys Inc.
- Osang Healthcare Co., Ltd.
- Dexcom South Korea
Recent Developments:
- In October 2025, i-SENS introduced smart AI-enabled blood glucose monitoring platforms integrated with cloud-based automated synchronization technologies for precise clinical trend tracking operations.
- In July 2025, SD Biosensor launched next-generation modular biosensing testing systems optimized for decentralized diagnostic applications, automated results delivery, and healthcare management tools requiring high-yield analytical accuracy.
Market Segmentation:
South Korea Self Monitoring Blood Glucose Devices Market, By Product Type
- Self-Monitoring Blood Glucose Meters
- Continuous Glucose Monitoring Subsystems
- Disposable Testing Strips
- Sterilized Lancet Devices
- Integrated Digital Testing Kits
South Korea Self Monitoring Blood Glucose Devices Market, By Technology
- AI-Based Analytical Platforms
- IoT-Enabled Biosensor Networks
- Bluetooth-Connected Sync Systems
- Cloud-Based Metric Portals
- Automated Error-Correction Software
South Korea Self Monitoring Blood Glucose Devices Market, By End-User Application
- Homecare Patient Settings
- Hospitals & Long-Term Care Wards
- Endocrinology Clinics & Labs
- Ambulatory Diagnostic Facilities
- Digital Health Research Institutes
Expert Views:
The market for diagnostic monitoring systems in South Korea will grow owing to the rise in the demand for precise metabolic tracking tools, the growing number of modernization of commercial clinics, and increasing demand for automated personal healthcare infrastructures. The inclusion of artificial intelligence based trend forecasting algorithms, Internet of Things enabled patient tracking platforms, and advanced precision hardware modules will enhance efficiency and boost the demand for blood glucose monitoring systems in the South Korean market.
Author: Govind and Krishna By Decisions Advisors and Consulting